Created in 2013 (Japan), DEFINDRA own 67 sister brands and 17477 competing brands. DEFINDRA is owned by Astellas Pharma, listed on the stock exchange of Francfort The ISIN, the company's International Securities Identification Number, is JP3942400007. DEFINDRA belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
Astellas Pharma
(DEFINDRA)
over 5 years*
EUR 6.32